• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于通过雾化将药物递送至肺部的脂质体。

Liposomes for drug delivery to the lungs by nebulization.

作者信息

Zaru Marco, Mourtas Spyridon, Klepetsanis Pavlos, Fadda Anna Maria, Antimisiaris Sophia G

机构信息

Department of Pharmacy, University of Patras, Rio, Greece.

出版信息

Eur J Pharm Biopharm. 2007 Nov;67(3):655-66. doi: 10.1016/j.ejpb.2007.04.005. Epub 2007 Apr 18.

DOI:10.1016/j.ejpb.2007.04.005
PMID:17540552
Abstract

Preparation of drug-loaded freeze-dried (FD) liposomes, designed for delivery to lungs after rehydration/nebulization was investigated. Rifampicin (RIF) incorporating multilamelar (MLV) and dried rehydrated vesicles (DRV); composed of phosphatidylcholine (PC), dipalmitoyloglycero-PC (DPPC) or distearoyloglycero-PC (DSPC), containing or not Cholesterol (Chol), were prepared. Vesicles were characterized for encapsulation efficiency (EE%), size distribution, zeta-potential, stability during freeze drying (FD) and nebulization (nebulization efficiency (NE%) and retention of RIF after nebulization (NER%)). Mucoadhesion and toxicity in A549 cells was measured. RIF EE% was not affected by liposome type but lipid composition was important; Synthetic lipid vesicles (DPPC and DSPC) had higher EE% compared to PC. As Chol increased EE% decreased. Freeze drying (FD) had no effect on EE%, however trehalose decreased EE% possibly due to RIF displacement. NER% was highly affected by lipid composition. Results of NE% and NER% for RIF-loaded liposomes show that DSPC/Chol (2:1) is the best composition for RIF delivery in vesicular form to lungs, by nebulization. Mucoadhesion and A549 cell toxicity studies were in line with this conclusion, however if mucoadhesion is required, improvement may be needed.

摘要

研究了用于复水/雾化后肺部给药的载药冻干脂质体的制备。制备了包含多层脂质体(MLV)和干燥复水囊泡(DRV)的利福平(RIF),其由磷脂酰胆碱(PC)、二棕榈酰甘油磷脂酰胆碱(DPPC)或二硬脂酰甘油磷脂酰胆碱(DSPC)组成,含有或不含有胆固醇(Chol)。对囊泡的包封率(EE%)、粒径分布、zeta电位、冻干(FD)和雾化过程中的稳定性(雾化效率(NE%)和雾化后利福平的保留率(NER%))进行了表征。测定了其在A549细胞中的黏膜黏附性和毒性。RIF的EE%不受脂质体类型的影响,但脂质组成很重要;与PC相比,合成脂质囊泡(DPPC和DSPC)具有更高的EE%。随着Chol含量增加,EE%降低。冻干(FD)对EE%没有影响,然而海藻糖可能由于RIF的置换而降低了EE%。NER%受脂质组成的影响很大。载RIF脂质体的NE%和NER%结果表明,DSPC/Chol(2:1)是通过雾化将RIF以囊泡形式递送至肺部的最佳组成。黏膜黏附性和A549细胞毒性研究与该结论一致,然而如果需要黏膜黏附性,则可能需要改进。

相似文献

1
Liposomes for drug delivery to the lungs by nebulization.用于通过雾化将药物递送至肺部的脂质体。
Eur J Pharm Biopharm. 2007 Nov;67(3):655-66. doi: 10.1016/j.ejpb.2007.04.005. Epub 2007 Apr 18.
2
PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.用于肺泡给药的聚乳酸-羟基乙酸共聚物(PLGA)、壳聚糖或壳聚糖包被的PLGA微粒?雾化过程中颗粒稳定性的比较研究。
Colloids Surf B Biointerfaces. 2008 Apr 1;62(2):220-31. doi: 10.1016/j.colsurfb.2007.10.005. Epub 2007 Oct 11.
3
Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.用于吸入的利福平脂质体干粉制剂的物理化学特性及稳定性
J Pharm Sci. 2009 Feb;98(2):628-39. doi: 10.1002/jps.21441.
4
Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.用于肺动脉高压气雾剂给药的含依洛前列素脂质体:制剂方面及稳定性
Pharm Res. 2007 Feb;24(2):277-87. doi: 10.1007/pl00022055. Epub 2006 Dec 27.
5
Chitosan-coated liposomes for delivery to lungs by nebulisation.用于通过雾化递送至肺部的壳聚糖包被脂质体。
Colloids Surf B Biointerfaces. 2009 Jun 1;71(1):88-95. doi: 10.1016/j.colsurfb.2009.01.010. Epub 2009 Jan 20.
6
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs.可吸入聚合物甘油酯体作为安全有效的利福平肺部递药载体。
Colloids Surf B Biointerfaces. 2016 Jul 1;143:301-308. doi: 10.1016/j.colsurfb.2016.03.044. Epub 2016 Mar 16.
7
The effects of freeze-drying on the stability of liposomes to jet nebulization.
J Pharm Pharmacol. 2001 Mar;53(3):393-8. doi: 10.1211/0022357011775451.
8
Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.用于结核病治疗的通过乙醇注入法制备的脂质体中卡那霉素的掺入。
J Pharm Pharmacol. 2005 Jan;57(1):23-30. doi: 10.1211/0022357055092.
9
Development of highly stable and low toxic cationic liposomes for gene therapy.用于基因治疗的高稳定性和低毒性阳离子脂质体的研发。
Arzneimittelforschung. 2008;58(10):485-92. doi: 10.1055/s-0031-1296545.
10
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.用于被动靶向肺泡巨噬细胞的载利福平脂质体:体外和体内评价
J Liposome Res. 2009;19(1):68-76. doi: 10.1080/08982100802610835.

引用本文的文献

1
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.用于治疗炎症性肺部疾病的基于纳米技术的可吸入药物递送系统。
Pharmaceutics. 2025 Jul 9;17(7):893. doi: 10.3390/pharmaceutics17070893.
2
Nanomaterial-enabled drug transport systems: a comprehensive exploration of current developments and future avenues in therapeutic delivery.纳米材料驱动的药物输送系统:治疗性给药当前进展与未来方向的全面探索
3 Biotech. 2024 Dec;14(12):289. doi: 10.1007/s13205-024-04135-y. Epub 2024 Nov 4.
3
Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome.
靶向巨噬细胞的脂质纳米颗粒递送 microRNA-146a 减轻失血性休克诱导的急性呼吸窘迫综合征。
ACS Nano. 2023 Sep 12;17(17):16539-16552. doi: 10.1021/acsnano.3c01814. Epub 2023 Aug 18.
4
Mucoadhesive Rifampicin-Liposomes for the Treatment of Pulmonary Infection by : Chitosan or ε-Poly-L-Lysine Decoration.壳聚糖或 ε-聚赖氨酸修饰的黏附性利福平脂质体治疗肺部感染。
Biomolecules. 2023 May 31;13(6):924. doi: 10.3390/biom13060924.
5
Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis.基于纳米技术的结核病治疗和管理的创新治疗方法。
Int J Nanomedicine. 2023 Mar 8;18:1159-1191. doi: 10.2147/IJN.S364634. eCollection 2023.
6
Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach.通过实验设计方法开发和优化可吸入表没食子儿没食子酸酯纳米脂质体作为肺动脉高压的潜在治疗方法
Pharmaceutics. 2023 Feb 6;15(2):539. doi: 10.3390/pharmaceutics15020539.
7
Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model.雾化异烟肼对小鼠模型中结核病的比活性研究。
Antibiotics (Basel). 2022 Nov 1;11(11):1527. doi: 10.3390/antibiotics11111527.
8
An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension.吸入性药物输送治疗肺动脉高压的最新进展和挑战。
Molecules. 2022 May 29;27(11):3490. doi: 10.3390/molecules27113490.
9
Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol.脂质体:结构、生物医学应用及稳定性参数,重点关注胆固醇
Front Bioeng Biotechnol. 2021 Sep 9;9:705886. doi: 10.3389/fbioe.2021.705886. eCollection 2021.
10
Improvement of Pulmonary Photodynamic Therapy: Nebulisation of Curcumin-Loaded Tetraether Liposomes.肺部光动力疗法的改进:载姜黄素四醚脂质体的雾化
Pharmaceutics. 2021 Aug 12;13(8):1243. doi: 10.3390/pharmaceutics13081243.